Frugal innovation for global surgery: leveraging lessons from low- and middle-income countries to optimise resource use and promote value-based care

LATEST ARTICLES
SEARCH INDEX
SUGGEST ARTICLE
THE OSI COLLECTIONS
AUDIOGRAM SERIES
ABOUT THE OSI
2020 SUMMARY

OSI STATISTICS

Open access articles:
934
Annotations added:
3
Countries represented:
107
No. of contributors:
13
Bookmarks made:
22

Frugal innovation for global surgery: leveraging lessons from low- and middle-income countries to optimise resource use and promote value-based care


JournalRCS Bulletin
Publication date – Jul – 2020
Authors – A Steyn, A Cassels-Brown, DF Chang, H Faal, R Vedanthan, R Venkatesh, CL Thiel
Keywordsglobal surgery, Innovation, lessons, Low-and middle-income countries
Open access – Yes
SpecialityHealth policy, Other
World region Global

Language – English
Submitted to the One Surgery Index on August 3, 2020 at 4:02 am
Abstract:

Limited or inconsistent access to necessary resources creates many challenges for delivering quality medical care in low- and middle-income countries (LMICs). These include funding and revenue, skilled clinical and allied health professionals, administrative expertise, reliable community infrastructure (eg water, electricity), functioning capital equipment and sufficient surgical supplies. Despite these challenges, some surgical care providers manage to provide cost effective, high quality care, offering lessons not only for other LMICs but also for high-income countries (HICs) that are working towards increasing value-based care. Examples would be how to optimise the consumption of resources, and reduce the environmental and public health burden of surgical care.

Owing to the liberal utilisation of capital equipment and single-use supplies, surgical care in HICs is increasingly recognised as a significant source of greenhouse gases and other environmental impacts that adversely affect human health. Regulations require many potentially reusable supplies and drugs to be discarded after single use. Supply manufacturers may label drugs or products as single-use to increase profit, reduce liability or facilitate regulatory approval. Many HICs struggle to increase the value of care while maximising quality and outcomes, and minimising cost and resource use.

OSI Number – 20625

Public annotations on this article:
No public annotations yet